Annual Report 2018

Section of Data Science Strategy

Takashi Kohno, Hirokazu Fukuda, Katsuya Tsuchihara, Shimon Tashiro, Genta Ohno

The Team and What We Do

 The mission of this section is to establish policies on how to collect and utilize genomic and clinical data of patients who received gene panel tests under the National Health Insurance System. The first one is on informed consent (IC) and it is established through a joint effort with Core Hospitals for Cancer Genome Medicine. The model IC form and S.O.P. for gene panel tests are prepared through discussions. The second one is to provide the collected genomic and clinical data for researchers at industrial and academic institutions in Japan and abroad. This section will help conduct a review board to provide the C-CAT data to those parties.

Activities

 The policy on IC was established with help of the Core Hospitals for Cancer Genomic Medicine and the model IC form and S.O.P. have been made. Prototypic videos and a draft pamphlet for patients to understand gene panel tests, IC and data submission to C-CAT have also been made. The policy outline on utilization of genomic and clinical data collected in C-CAT has also been established.

Future Prospects

 The video and pamphlet will be distributed to the Core and Liaison Hospitals for Cancer Genome Medicine before starting gene panel tests under the National Health Insurance System in June 2019. In addition, the basic policies on how to provide genomic and clinical data collected in C-CAT will be established in 2019. The basic design of a portal site system to share C-CAT data with faculties of the Core and Liaison Hospitals for Cancer Genome Medicine as well as researchers of industrial and academic institutions will also be started.